Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients

Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients

Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipi...

Full description

Bibliographic Details
Main Authors: H Eskandari Naji, A Ghorbanihaghjo, H Argani, S Raeisi, J Safa, AH Alirezaei, N Rashtchizadeh
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-04-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Renal dialysis
TL1 cytokine [Supplementary Concept]
sTWEAK
Kidney transplantation
Fibroblast growth factor 23 [Supplementary Concept]
Online Access:http://www.ijotm.com/ojs/index.php/IJOTM/article/view/338

Internet

http://www.ijotm.com/ojs/index.php/IJOTM/article/view/338

Similar Items